SlideShare une entreprise Scribd logo
1  sur  4
Télécharger pour lire hors ligne
COUNTERFEIT MEDICINE
Dr Indrajeet Kumar
.
Department of Community Medicine
M.G.M Medical College, Jamshedpur

Definition: “
Drugs/Medicines produced with an intention to
cheat a person are called counterfeit drugs.”
This includes/involves:mislabelling (includes false expiry date).
no active ingredients
a wrong ingredient
or correct ingredient in an insufficient quantity.
S
ub- s
tandard Medicine are genuine medicines produced by
legitimate (in accordance to law) that does not meet the quality
specifications that the producer says they meet.
e.g: they may contain less or more active ingredient than
written on package. This may not be an intention to cheat but
may be due to problems with the manufacturing process.

Most frequently counterfeited medicines are the expensive ones
eg: the hormones,
costly antibiotics,
anticancer drugs,
anti- tuberculosis drugs, etc.
E
xtent of the P
roblem:In global market it is 10%
Developing counties 25%
In some countries it is upto 50%
E
ffect: therapeutic failure or drug resistance,
in some cases death

F
actorsencouraging counterfeiting of drugs
:
A profitable business.
Absence of strong punishable legislation

Great price difference between identical products.
Internet based sales of pharmaceutical products.
Action to addres sub- s
s
tandard and Counterfeit medicines
:
S
trong legislation against manufacturing and sale of
counterfeit drugs.
Use of MARKE of authenticity e.g:S
RS
MScode on the back
of wrapper, QR code.
S
urveillance for fake and sub- standard drugs.
E
ducating patients and health workers.

Contenu connexe

Tendances

Counterfeit drugs presentation to Pharmacy-3 students in South Dakota
Counterfeit drugs presentation to Pharmacy-3 students in South DakotaCounterfeit drugs presentation to Pharmacy-3 students in South Dakota
Counterfeit drugs presentation to Pharmacy-3 students in South DakotaThe Partnership For Safe Medicines
 
Detection of Counterfeit Drugs and Other Products
Detection of Counterfeit Drugs and Other ProductsDetection of Counterfeit Drugs and Other Products
Detection of Counterfeit Drugs and Other ProductsNancy Sperling
 
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...OECD Governance
 
Counterfeits Kill
Counterfeits KillCounterfeits Kill
Counterfeits Killcmebahamas
 
OECD EUIPO Trade in Counterfeit Pharmaceutical Products
OECD EUIPO Trade in Counterfeit Pharmaceutical ProductsOECD EUIPO Trade in Counterfeit Pharmaceutical Products
OECD EUIPO Trade in Counterfeit Pharmaceutical ProductsOECD Governance
 
White paper stopping counterfeit pharmaceuticals 0309
White  paper stopping counterfeit pharmaceuticals 0309White  paper stopping counterfeit pharmaceuticals 0309
White paper stopping counterfeit pharmaceuticals 0309NEW Momentum
 
‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical marketNitin Patel
 
Patient advocate townhall: keeping patients safe from counterfeit drugs
Patient advocate townhall: keeping patients safe from counterfeit drugsPatient advocate townhall: keeping patients safe from counterfeit drugs
Patient advocate townhall: keeping patients safe from counterfeit drugsThe Partnership For Safe Medicines
 
Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...
Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...
Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...Alfons Futterer
 
Toc project roll no
Toc project  roll no Toc project  roll no
Toc project roll no pdf uploader
 
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar..."Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...The Partnership For Safe Medicines
 
Top Trends in Orphan Drugs
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan DrugsBill Smith
 
Measuring the Relationship between Innovative Drugs and AE_2015
Measuring the Relationship between Innovative Drugs and AE_2015Measuring the Relationship between Innovative Drugs and AE_2015
Measuring the Relationship between Innovative Drugs and AE_2015Jonathan Bryan
 
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...The Partnership For Safe Medicines
 
False Advertising in the Drug and Food Industries
False Advertising in the Drug and Food Industries  False Advertising in the Drug and Food Industries
False Advertising in the Drug and Food Industries JoshuaRiger
 

Tendances (20)

Counterfeit drugs presentation to Pharmacy-3 students in South Dakota
Counterfeit drugs presentation to Pharmacy-3 students in South DakotaCounterfeit drugs presentation to Pharmacy-3 students in South Dakota
Counterfeit drugs presentation to Pharmacy-3 students in South Dakota
 
Detection of Counterfeit Drugs and Other Products
Detection of Counterfeit Drugs and Other ProductsDetection of Counterfeit Drugs and Other Products
Detection of Counterfeit Drugs and Other Products
 
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...
 
Counterfeit Drugs in America: 2017 Overview
Counterfeit Drugs in America: 2017 OverviewCounterfeit Drugs in America: 2017 Overview
Counterfeit Drugs in America: 2017 Overview
 
Counterfeits Kill
Counterfeits KillCounterfeits Kill
Counterfeits Kill
 
OECD EUIPO Trade in Counterfeit Pharmaceutical Products
OECD EUIPO Trade in Counterfeit Pharmaceutical ProductsOECD EUIPO Trade in Counterfeit Pharmaceutical Products
OECD EUIPO Trade in Counterfeit Pharmaceutical Products
 
White paper stopping counterfeit pharmaceuticals 0309
White  paper stopping counterfeit pharmaceuticals 0309White  paper stopping counterfeit pharmaceuticals 0309
White paper stopping counterfeit pharmaceuticals 0309
 
Offlabel strategy
Offlabel strategyOfflabel strategy
Offlabel strategy
 
‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market
 
Patient advocate townhall: keeping patients safe from counterfeit drugs
Patient advocate townhall: keeping patients safe from counterfeit drugsPatient advocate townhall: keeping patients safe from counterfeit drugs
Patient advocate townhall: keeping patients safe from counterfeit drugs
 
drugpricingstudy
drugpricingstudydrugpricingstudy
drugpricingstudy
 
Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...
Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...
Best Practices for Traditional Chinese Medicine Companies to Improve Traceabi...
 
China
ChinaChina
China
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Orphan Drug 101
 
Toc project roll no
Toc project  roll no Toc project  roll no
Toc project roll no
 
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar..."Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
 
Top Trends in Orphan Drugs
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan Drugs
 
Measuring the Relationship between Innovative Drugs and AE_2015
Measuring the Relationship between Innovative Drugs and AE_2015Measuring the Relationship between Innovative Drugs and AE_2015
Measuring the Relationship between Innovative Drugs and AE_2015
 
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
 
False Advertising in the Drug and Food Industries
False Advertising in the Drug and Food Industries  False Advertising in the Drug and Food Industries
False Advertising in the Drug and Food Industries
 

En vedette

Discourse analysis-1225482185740463-9
Discourse analysis-1225482185740463-9Discourse analysis-1225482185740463-9
Discourse analysis-1225482185740463-9Victor Canoy
 
Windows Server 2012 Licensing
Windows Server 2012 LicensingWindows Server 2012 Licensing
Windows Server 2012 Licensingcembalik
 
Gallardo Graphics Slide Show
Gallardo Graphics Slide ShowGallardo Graphics Slide Show
Gallardo Graphics Slide ShowJanice Walters
 
Essential medicine print
Essential medicine printEssential medicine print
Essential medicine printPsm Dept
 
Fluturas presentation @ Big Data Conclave
Fluturas presentation @ Big Data ConclaveFluturas presentation @ Big Data Conclave
Fluturas presentation @ Big Data Conclavefluturads
 

En vedette (9)

Kerja aina
Kerja ainaKerja aina
Kerja aina
 
Discourse analysis-1225482185740463-9
Discourse analysis-1225482185740463-9Discourse analysis-1225482185740463-9
Discourse analysis-1225482185740463-9
 
Windows Server 2012 Licensing
Windows Server 2012 LicensingWindows Server 2012 Licensing
Windows Server 2012 Licensing
 
Nipt
NiptNipt
Nipt
 
Teamwork
TeamworkTeamwork
Teamwork
 
Gallardo Graphics Slide Show
Gallardo Graphics Slide ShowGallardo Graphics Slide Show
Gallardo Graphics Slide Show
 
Essential medicine print
Essential medicine printEssential medicine print
Essential medicine print
 
Fluturas presentation @ Big Data Conclave
Fluturas presentation @ Big Data ConclaveFluturas presentation @ Big Data Conclave
Fluturas presentation @ Big Data Conclave
 
Fruits
FruitsFruits
Fruits
 

Similaire à Counterfeit medicine print

International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)inventionjournals
 
Multiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit DrugsMultiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit Drugsguest696d96
 
Multiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit DrugsMultiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit DrugsSanjay Modi
 
Med counterfiet
Med counterfietMed counterfiet
Med counterfietsuneseal
 
Importance of forensic lab in pharmacy
Importance of forensic lab in pharmacyImportance of forensic lab in pharmacy
Importance of forensic lab in pharmacyM Habib
 
Ethics in pharma industry
Ethics in pharma industryEthics in pharma industry
Ethics in pharma industryDr Qureshi
 
A partnership model for the control of unethical marketing of medical drugs i...
A partnership model for the control of unethical marketing of medical drugs i...A partnership model for the control of unethical marketing of medical drugs i...
A partnership model for the control of unethical marketing of medical drugs i...Alexander Decker
 
Big pharma and modern medicine
Big pharma and modern medicineBig pharma and modern medicine
Big pharma and modern medicinesohrab642
 
Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Shaukat Patel MS R.Ph.
 
Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Shaukat Patel MS R.Ph.
 
Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)
Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)
Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)Afifah Nabilah
 
Market access conference NAPM
Market access conference NAPMMarket access conference NAPM
Market access conference NAPMnapmSA
 
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse pptshahin ghori
 
" GENERIC MEDICINE''
" GENERIC MEDICINE''" GENERIC MEDICINE''
" GENERIC MEDICINE''Ajay Baykar
 
Forensic pharmacovigilance: Newer dimension of pharmacovigilance
Forensic pharmacovigilance: Newer dimension of pharmacovigilanceForensic pharmacovigilance: Newer dimension of pharmacovigilance
Forensic pharmacovigilance: Newer dimension of pharmacovigilanceRosmirella Cano Rojas
 

Similaire à Counterfeit medicine print (20)

TOC PROJECT PPT
TOC PROJECT PPTTOC PROJECT PPT
TOC PROJECT PPT
 
International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)
 
Multiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit DrugsMultiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit Drugs
 
Multiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit DrugsMultiple Strategies and Technologies to Combat Counterfeit Drugs
Multiple Strategies and Technologies to Combat Counterfeit Drugs
 
BOGUS DRUGS
BOGUS DRUGSBOGUS DRUGS
BOGUS DRUGS
 
Med counterfiet
Med counterfietMed counterfiet
Med counterfiet
 
Importance of forensic lab in pharmacy
Importance of forensic lab in pharmacyImportance of forensic lab in pharmacy
Importance of forensic lab in pharmacy
 
Ethics in pharma industry
Ethics in pharma industryEthics in pharma industry
Ethics in pharma industry
 
A partnership model for the control of unethical marketing of medical drugs i...
A partnership model for the control of unethical marketing of medical drugs i...A partnership model for the control of unethical marketing of medical drugs i...
A partnership model for the control of unethical marketing of medical drugs i...
 
Big pharma and modern medicine
Big pharma and modern medicineBig pharma and modern medicine
Big pharma and modern medicine
 
Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)
 
Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)
 
Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)
Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)
Case Study: Treating AIDs: The Global Ethical Dilemma (MGT4810)
 
Market access conference NAPM
Market access conference NAPMMarket access conference NAPM
Market access conference NAPM
 
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse ppt
 
Promoting Rational drugs in NRHM
Promoting Rational drugs in NRHMPromoting Rational drugs in NRHM
Promoting Rational drugs in NRHM
 
" GENERIC MEDICINE''
" GENERIC MEDICINE''" GENERIC MEDICINE''
" GENERIC MEDICINE''
 
Forensic pharmacovigilance: Newer dimension of pharmacovigilance
Forensic pharmacovigilance: Newer dimension of pharmacovigilanceForensic pharmacovigilance: Newer dimension of pharmacovigilance
Forensic pharmacovigilance: Newer dimension of pharmacovigilance
 
Generic drugs
Generic drugsGeneric drugs
Generic drugs
 
Med errors apa
Med errors  apaMed errors  apa
Med errors apa
 

Plus de Psm Dept

Bird flu for 3rd year
Bird flu for 3rd yearBird flu for 3rd year
Bird flu for 3rd yearPsm Dept
 
Vit a print
Vit a printVit a print
Vit a printPsm Dept
 
Nutrition & dietetics (2)
Nutrition & dietetics (2)Nutrition & dietetics (2)
Nutrition & dietetics (2)Psm Dept
 
Acute diarrhoeal diseases for mail
Acute   diarrhoeal   diseases for mailAcute   diarrhoeal   diseases for mail
Acute diarrhoeal diseases for mailPsm Dept
 

Plus de Psm Dept (7)

Bird flu for 3rd year
Bird flu for 3rd yearBird flu for 3rd year
Bird flu for 3rd year
 
Phc visit
Phc visitPhc visit
Phc visit
 
Polio
Polio Polio
Polio
 
Vit a print
Vit a printVit a print
Vit a print
 
Nutrition & dietetics (2)
Nutrition & dietetics (2)Nutrition & dietetics (2)
Nutrition & dietetics (2)
 
Opv
OpvOpv
Opv
 
Acute diarrhoeal diseases for mail
Acute   diarrhoeal   diseases for mailAcute   diarrhoeal   diseases for mail
Acute diarrhoeal diseases for mail
 

Counterfeit medicine print

  • 1. COUNTERFEIT MEDICINE Dr Indrajeet Kumar . Department of Community Medicine M.G.M Medical College, Jamshedpur Definition: “ Drugs/Medicines produced with an intention to cheat a person are called counterfeit drugs.” This includes/involves:mislabelling (includes false expiry date). no active ingredients a wrong ingredient or correct ingredient in an insufficient quantity.
  • 2. S ub- s tandard Medicine are genuine medicines produced by legitimate (in accordance to law) that does not meet the quality specifications that the producer says they meet. e.g: they may contain less or more active ingredient than written on package. This may not be an intention to cheat but may be due to problems with the manufacturing process. Most frequently counterfeited medicines are the expensive ones eg: the hormones, costly antibiotics, anticancer drugs, anti- tuberculosis drugs, etc.
  • 3. E xtent of the P roblem:In global market it is 10% Developing counties 25% In some countries it is upto 50% E ffect: therapeutic failure or drug resistance, in some cases death F actorsencouraging counterfeiting of drugs : A profitable business. Absence of strong punishable legislation Great price difference between identical products. Internet based sales of pharmaceutical products.
  • 4. Action to addres sub- s s tandard and Counterfeit medicines : S trong legislation against manufacturing and sale of counterfeit drugs. Use of MARKE of authenticity e.g:S RS MScode on the back of wrapper, QR code. S urveillance for fake and sub- standard drugs. E ducating patients and health workers.